Gene Logic Inc. (MM) 뉴스 - GLGC | 주식 나스닥

개인 투자자를 위한 전문가급 도구.

Gene Logic to Announce Fourth Quarter and Full Year 2005 Financial Results on February 24, 2006

Gene Logic Inc. (NASDAQ:GLGC) announced today that it will release Fourth Quarter and Full Year 2005 financial results on Friday, February 24...

Gene Logic Recruits Top Talent for Key Positions in Its Nonclinical Business; Suzanne Mullins, Vice President of Quality Systems

Tracey McNamara, DVM, Veterinary Pathologist, Was a Key Figure in Identifying West Nile Virus in the U.S. ? Gene Logic Inc. (NASDAQ:GLGC...

Gene Logic to Present at the 2005 Rodman and Renshaw Techvest 7th Annual Healthcare Conference

Gene Logic Inc. (NASDAQ:GLGC) announced today that its Chief Executive Officer and President, Mark D. Gessler, will present at the 2005 Rodman and...

Gene Logic Reports Third Quarter 2005 Financial Results; Signs Drug Repositioning Agreement with Pfizer; Achieves Profitability

Gene Logic Inc. (NASDAQ:GLGC) today reported financial results for the third quarter and nine months ended September 30, 2005. ? Quarterly...

Gene Logic to Announce Third Quarter 2005 Financial Results on October 28, 2005

Gene Logic Inc. (NASDAQ:GLGC) announced today that it will release Third Quarter 2005 financial results on Friday, October 28, 2005 at 7:00 a.m...

Gene Logic Releases ASCENTA(R) System 2.0; New Version Includes Innovative Tools to Identify Gene Targets and Biomarkers in Huma

Gene Logic Inc. (NASDAQ: GLGC) today released ASCENTA(R) System 2.0, a robust new version of its existing web-based product for gene and biomarker...

Xenogen Announces Second Agreement With Gene Logic

Gene Logic Integrates Both Xenogen's Proprietary Biophotonic Imaging Technology and Custom Animal Model Generation into Its New Drug Repositioning...

Gene Logic Enters Agreement with Pfizer to Reposition Significant Number of Drug Candidates from a Broad Range of Therapeutic Ar

Agreement with World's Largest Pharmaceutical Company Includes Success-Based Milestones plus Royalties on Repositioned Drug Candidates ?...

Gene Logic Announces Goodwill Impairment Related to its Nonclinical Services Subsidiary

Gene Logic Inc. (NASDAQ:GLGC) announced today that in conjunction with its annual strategic planning process and annual testing for impairment of...

Gene Logic to Present at the 2005 UBS Global Life Sciences Conference

Gene Logic Inc. (NASDAQ:GLGC) announced today that Chief Executive Officer and President Mark D. Gessler will present at the 2005 UBS Global Life...

Gene Logic to Present at Thomas Weisel Partners' 2005 Healthcare Conference

Gene Logic Inc. (NASDAQ:GLGC) announced today that Chief Executive Officer and President Mark D. Gessler will present at the Thomas Weisel...

Gene Logic Reports Second Quarter 2005 Financial Results; Net Loss Narrows by 41%; Genomics Achieves Profitability for Second Co

Gene Logic Inc. (NASDAQ:GLGC) today reported financial results for the second quarter ended June 30, 2005. ? Led by the second consecutive...

Gene Logic Signs Agreement with GE Healthcare to Distribute New Gene Expression Analysis System to Academic, Government and Othe

Gene Logic Inc. (NASDAQ:GLGC) announced today it has signed an agreement with GE Healthcare for global distribution of Gene Logic's new...

Gene Logic to Announce Second Quarter 2005 Financial Results on July 20, 2005

Gene Logic Inc. (NASDAQ:GLGC) announced today that it will release Second Quarter 2005 financial results on Wednesday, July 20, 2005 at 7:00 a.m...

Gene Logic Expands Contract Study Services Capacity by More Than 50 Percent to Meet Growing Pharmaceutical Industry Need; With A

Gene Logic Inc. (NASDAQ:GLGC) announced today it has completed expansion and upgrade of its contract study services facilities, increasing its...

janice shell 2 분 전

I'll be damned!! But it's a good thing for him finally to be right about!!

HeavenBound83 2 분 전

Well in that case, congrats to you for winning at your appointed time! We're all in this to win, no matter the portions of those winnings. Nonetheless, I believe the patient will most definitely win big in the end. As always, good luck to all smart money :-)

HMBL

gitreal 2 분 전

Thank you for solid info. Convinced my self to finally sell a few(original investment)

Poor Rich, being fed misinformation by other Ihub posters, and making decisions based on nonsense.

How do you even get through the day, being so gullible?

NBRI

TKS PARTY 2 분 전

I'm relaxed and ready for takeoff. I'm sure we are already including yourself!!! Good luck and may the force be with you ! Welcome back

CBRF

DruidOracle55 3 분 전

Can't wait on axxa & Space X collab.

AXXA

ClayTrader 3 분 전

VIDEO: / $NQ, / $ES, / $YM, / $CL, / $GC Futures Technical Chart Analysis for February 20-21, 2025

https://youtu.be/abmyxg_k4-Q

CL ES GC

ClayTrader 3 분 전

VIDEO: / $NQ, / $ES, / $YM, / $CL, / $GC Futures Technical Chart Analysis for February 20-21, 2025

https://youtu.be/abmyxg_k4-Q

CL ES GC

Mauigold 3 분 전

Somewhere… There’s a village missing their idiot.

AVXL

ClayTrader 3 분 전

VIDEO: / $NQ, / $ES, / $YM, / $CL, / $GC Futures Technical Chart Analysis for February 20-21, 2025

https://youtu.be/abmyxg_k4-Q

CL ES GC

The GidDy uP Kid 3 분 전

HEPA catching after hours and eod…

HEPA

Vexari 3 분 전

How many are randomly selected

Patrick Bateman 3 분 전

It can be entertaining. I'll give ya that

RITE

The GidDy uP Kid 3 분 전

HEPA catching after hours and eod…

HEPA

MartinLutherKing 4 분 전

It’s coming…. Cancer cure TTX 100% remission

RNAZ

IH Admin [Shelly] 4 분 전

I don't think anyone's looking at it because it doesn't appear as if it's necessarily an issue on our end. Again, if moving PMs to Archive helped before, I'd try moving even more and keeping the number lower.

PutzMueler 4 분 전

What else is new?

Public company’s have to hold an AGM within six months of the start of the last financial year.

They didn’t do that either

uksausage 5 분 전

NEW YORK, NY / ACCESS Newswire / February 20, 2025 / INNODATA INC.
INOD
today reported results for the fourth quarter and the year ended December 31, 2024.

Revenue for the fourth quarter was $59.2 million, up 127% from revenue of $26.1 million in the same period last y

INOD

georgie18 5 분 전

LIDR...86...🥳...Great Earnings Report...https://www.businesswire.com/news/home/20250220092786/en

LIDR

DruidOracle55 5 분 전

This is the next "amazon" coupled with Space X and with added bonus of quantum teleportation services.

AXXA

janice shell 5 분 전

Not to mention rockets to Mars!!

georgie18 5 분 전

LIDR...86...🥳...Great Earnings Report...https://www.businesswire.com/news/home/20250220092786/en

LIDR

DruidOracle55 5 분 전

This is the next "amazon" coupled with Space X and with added bonus of quantum teleportation services.

AXXA

georgie18 6 분 전

LIDR...86...🥳...Great Earnings Report...https://www.businesswire.com/news/home/20250220092786/en

LIDR

georgie18 6 분 전

LIDR...86...🥳...Great Earnings Report...https://www.businesswire.com/news/home/20250220092786/en

LIDR

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Gene Logic Inc. (MM) (GLGC)

개인 투자자를 위한 전문가급 도구.

GLGC 뉴스

Gene Logic to Announce Fourth Quarter and Full Year 2005 Financial Results on February 24, 2006

Gene Logic Recruits Top Talent for Key Positions in Its Nonclinical Business; Suzanne Mullins, Vice President of Quality Systems

Gene Logic to Present at the 2005 Rodman and Renshaw Techvest 7th Annual Healthcare Conference

Gene Logic Reports Third Quarter 2005 Financial Results; Signs Drug Repositioning Agreement with Pfizer; Achieves Profitability

Gene Logic to Announce Third Quarter 2005 Financial Results on October 28, 2005

Gene Logic Releases ASCENTA(R) System 2.0; New Version Includes Innovative Tools to Identify Gene Targets and Biomarkers in Huma

Xenogen Announces Second Agreement With Gene Logic

Gene Logic Enters Agreement with Pfizer to Reposition Significant Number of Drug Candidates from a Broad Range of Therapeutic Ar

Gene Logic Announces Goodwill Impairment Related to its Nonclinical Services Subsidiary

Gene Logic to Present at the 2005 UBS Global Life Sciences Conference

Gene Logic to Present at Thomas Weisel Partners' 2005 Healthcare Conference

Gene Logic Reports Second Quarter 2005 Financial Results; Net Loss Narrows by 41%; Genomics Achieves Profitability for Second Co

Gene Logic Signs Agreement with GE Healthcare to Distribute New Gene Expression Analysis System to Academic, Government and Othe

Gene Logic to Announce Second Quarter 2005 Financial Results on July 20, 2005

Gene Logic Expands Contract Study Services Capacity by More Than 50 Percent to Meet Growing Pharmaceutical Industry Need; With A

토론

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Gene Logic Inc. (MM) (GLGC) 뉴스

Gene Logic Inc. (MM) (GLGC)

개인 투자자를 위한 전문가급 도구.

GLGC 뉴스

Gene Logic to Announce Fourth Quarter and Full Year 2005 Financial Results on February 24, 2006

Gene Logic Recruits Top Talent for Key Positions in Its Nonclinical Business; Suzanne Mullins, Vice President of Quality Systems

Gene Logic to Present at the 2005 Rodman and Renshaw Techvest 7th Annual Healthcare Conference

Gene Logic Reports Third Quarter 2005 Financial Results; Signs Drug Repositioning Agreement with Pfizer; Achieves Profitability

Gene Logic to Announce Third Quarter 2005 Financial Results on October 28, 2005

Gene Logic Releases ASCENTA(R) System 2.0; New Version Includes Innovative Tools to Identify Gene Targets and Biomarkers in Huma

Xenogen Announces Second Agreement With Gene Logic

Gene Logic Enters Agreement with Pfizer to Reposition Significant Number of Drug Candidates from a Broad Range of Therapeutic Ar

Gene Logic Announces Goodwill Impairment Related to its Nonclinical Services Subsidiary

Gene Logic to Present at the 2005 UBS Global Life Sciences Conference

Gene Logic to Present at Thomas Weisel Partners' 2005 Healthcare Conference

Gene Logic Reports Second Quarter 2005 Financial Results; Net Loss Narrows by 41%; Genomics Achieves Profitability for Second Co

Gene Logic Signs Agreement with GE Healthcare to Distribute New Gene Expression Analysis System to Academic, Government and Othe

Gene Logic to Announce Second Quarter 2005 Financial Results on July 20, 2005

Gene Logic Expands Contract Study Services Capacity by More Than 50 Percent to Meet Growing Pharmaceutical Industry Need; With A

토론

최근 히스토리

회사 소개

사업

Popular

앱 받기

광고 제거